| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |